Skip to main content
Premium Trial:

Request an Annual Quote

Inova Lands $50M Gift for Personalized Oncology Research

NEW YORK (GenomeWeb) – Inova recently announced a $50 million gift from Dwight Schar to launch a new oncology research institute at the Inova Center for Personalized Health in Fairfax, Virginia.

The gift will establish the Dwight and Martha Schar Cancer Institute to develop and apply genomic personalized medicine in cancer treatment.

Donald "Skip" Trump will lead the cancer institute as CEO and executive director, Inova said. 

The Inova Center for Personalized Health is part of the Inova Health System, a non-profit healthcare provider in Northern Virginia and the Washington, DC metro area. The Inova Translational Medicine Institute is also a part of the Inova system.

In a separate statement, the Fairfax County Economic Development Authority said that the new institute has as its goal, the creation of a leading center for translational cancer research and patient care based on genomics and individualized therapy. Researchers at the institute will develop new genomics-based tests, therapies, and population health processes. The institute will also collaborate with life science firms, resulting in the expansion of the life science economy in the Virginia and Washington region.

In April 2014, Inova announced it planned to offer whole-genome sequencing by prescription for sick newborns.